|4Apr 18, 6:30 PM ET

Cellectar Biosciences, Inc. 4

4 · Cellectar Biosciences, Inc. · Filed Apr 18, 2017

Insider Transaction Report

Form 4
Period: 2017-04-17
Friend John E. II
Chief Medical Officer
Transactions
  • Award

    Common stock

    2017-04-17+100,000100,000 total
Footnotes (1)
  • [F1]Common stock grant that vests in equal annual increments over a period of three years from the date of grant.

Documents

1 file
  • 4
    v464509_form4.xmlPrimary

    FORM 4